Prosensa - Developing therapies for neuromuscular diseases

  • Home
  • Patients & Family
  • HC professionals
  • Technology & Products
  • Press room
  • About Prosensa
  • Contact Us

Sitemap

  • Patients & Family

    • Patients & Family overview
    • Duchenne Muscular Dystrophy

      • Patient Stories
      • Patient Organizations
      • FAQ
    • Myotonic Dystrophy

    • Huntington's Disease

    • Spinal Muscular Atrophy

  • HC Professionals

    • HC Professionals overview
    • Duchenne Muscular Dystrophy

    • Myotonic Dystrophy

    • Huntington's Disease

    • Spinal Muscular Atrophy

  • Technology & Products

    • Technology & Products overview
    • RNA Modulation

    • Exon Skipping

    • Pipeline

      • PRO051/GSK2402968
      • PRO044
      • Preclinical Portfolio
      • Discovery Portfolio
    • IP Portfolio

  • About Prosensa

    • About Prosensa overview
    • Company Profile

    • Strategy

    • Management Team

    • Supervisory Board

    • Scientific & Clinical Advisory

    • Investors

    • Partners

    • Careers

    • Contact Us

  • Press Room

    • Press Room overview
    • Press Releases

    • Media Gallery

  • General pages

    • Home
    • Privacy Policy
    • Sitemap

Footer navigation

  • Contact Us
  • Sitemap
  • Privacy Policy
  • Disclaimer

© 2010 Prosensa Therapeutics B.V.